Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairm...(per (loss) per In millions e...)

Date:2/26/2009

per (loss) per In millions, except per income diluted income diluted share data share* share* GAAP results $(2,430) $(1.62) $(2,394) $(1.59) Non-GAAP adjustments: Goodwill and intangible asset impairment charges 2,681 1.78 2,627 1.74 Acquisition-related charges 25 0.02 25 0.02 Restructuring-related charges 27 0.02 27 0.02 Discrete tax items (109) (0.07) (109) (0.07) Amortization expense 126 0.08 126 0.08 Adjusted results $320 $0.21 $302 $0.20 * Assumes dilution of 2.7 million shares for all or a portion of these amounts. An explanation of the Company's use of these non-GAAP measures is provided at the end of this document. BOSTON SCIENTIFIC CORPORATION NON-GAAP NET INCOME AND NET INCOME PER COMMON SHARE RECONCILIATIONS (CONT.) (Unaudited) Three Months Ended December 31, 2008 Previously As Updated Reported Goodwill and intangible asset impairment charges: Goodwill and intangible asset impairment charges $2,689 $2,635 Less: Income tax benefit (a) (8) (8) Goodwill and intangible asset impairment charges, net of tax $2,681 $2,627 Acquisition-related charges: Purchased research and developmen
'/>"/>

SOURCE Boston Scientific Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
2. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
3. Boston Scientific Acquires Labcoat Limited
4. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
5. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
6. Boston Scientific to Participate in Piper Jaffray Health Care Conference
7. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
8. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
9. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
10. InterMune to Present at Deutsche Bank Biotech Boston Confab
11. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability